Brent Hatzis-Schoch, See Remarks at Black Diamond Therapeutics, Inc. (BDTX), bought 3,000 shares at $19.00 ($57K) on 2020-02-03, disclosed to the SEC on 2020-02-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BDTX | SELL | 2021-03-16 | $215K | — | Filing → |
| BDTX | SELL | 2021-02-12 | $214K | — | Filing → |
| BDTX | SELL | 2021-01-14 | $506K | — | Filing → |